A new Periodic Transaction Report filed with the U.S. House of Representatives shows that Hon. Gilbert Cisneros sold shares of Lumentum Holdings Inc. common stock (LITE) on July 17, 2026. The transaction was made personally by the member of Congress and is valued in the disclosed range of $1,001 to $15,000. The holding was reported through 150 Main Street Trust, held at Bank of America.
Under the STOCK Act, members of Congress and certain staff are required to disclose transactions in individual stocks, bonds, and other securities within 30 to 45 days of execution. This filing falls squarely within that requirement, and our internal system has classified it simply as a congress sale — a routine disclosure category that flags any reported sale by a lawmaker without making any judgment about intent or timing.
A Notable Overlap With Insider Activity
What makes this filing worth tracking is its proximity to another sale of the same stock. Company insider Wupen Yuen also sold shares of Lumentum Holdings on August 15, 2026, in a transaction valued at $3,464,690. That sale occurred within roughly 30 days of Cisneros’s own reported transaction date, placing both disclosures in a similar window.
It’s worth being clear about what this overlap does and does not mean. STOCK Act filings and Form 4 insider filings are separate disclosure regimes with different reporting deadlines, different thresholds, and different purposes. A lawmaker’s sale and a corporate insider’s sale occurring near the same calendar period does not establish any connection between the two, nor does it suggest coordination or access to non-public information. Both disclosures are legally required regardless of the underlying reason for the trade, and neither filing by itself indicates wrongdoing.
Still, when a member of Congress and a company insider both reduce their position in the same security within a short window, it becomes a useful data point for readers tracking patterns across both congressional and corporate trading activity. Cross-referencing these two disclosure streams is part of how we surface signals that might otherwise sit in separate silos — one filed with the House Clerk’s office, the other with the SEC.
Readers interested in how institutional money managers are positioning around similar names may also want to see our ongoing coverage of fund-level portfolio changes, such as our tracking of OSSIAM’s quarterly 13F portfolio moves, which offers a complementary view of how larger holders adjust exposure over time.
As with all Periodic Transaction Reports, this filing reflects a required disclosure rather than a recommendation or signal to act on. We’ll continue monitoring for any amended filings or related activity tied to LITE in the coming weeks.